Delivery Order SPE2DB24D1007-SPE2DB25FCAEN
Award Date
2/7/25
Potential Completion Date
2/10/25
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,071.18, is for the supply of KISQALI 600 MG DAILY DOSE 63S, a medication, and has a completion date of December 19, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of KISQALI 400 MG DAILY DOSE 42S medication. The contract has a firm fixed price of $90,600.63 and a completion date of January 27, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,738.55 firm fixed price contract is for the supply of KISQALI 600 MG DAILY DOSE 63S, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a $23,508.75 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is to provide KISQALI 600 MG DAILY DOSE 63S, a specialty pharmaceutical product, with a period of performance through October 6, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product KISQALI 600 MG DAILY DOSE 63S, with a total ceiling value of $27,592.55 and a period of performance through April 19, 2024. The contract is a Firm Fixed Price delivery order, without any set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KISQALI 400 MG DAILY DOSE 42S, a specialty medication. The firm-fixed-price delivery order, valued at $21,715.54, has a completion date of November 20, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,281.68 contract is for the supply of KISQALI 400 MG DAILY DOSE 42S, a prescription medication, to support federal healthcare programs. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,793.24 Firm Fixed Price Delivery Order contract is for the supply of KISQALI 600 MG DAILY DOSE 63S, a pharmaceutical product. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of pharmaceutical products and medical supplies, including KISQALI 400 MG DAILY DOSE 42S, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $10,668.04 and an ultimate completion date of May 9, 2024. It is a delivery order contract with a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a $9,923.50 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KISQALI 600 MG DAILY DOSE 63S, a specialty oncology medication. The award has an ultimate completion date of August 21, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at...